etherna immunotherapies NV (“etherna”), a technology platform leader pioneering mRNA and lipid-based nanopar...
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, in partnership ...
Researchers at the National University of Singapore (NUS) have developed a non-invasive method to improve the effectiven...
A native of Ahmedabad and an expert in the field of drug development, Dr Jogin Desai incorporated his startup Eyestem Re...
The Australian government is investing $18.5 million to help eight Australian startup companies to commercialise their r...
Researchers from the Yong Loo Lin School of Medicine (NUS Medicine) in Singapore have developed a groundbreaking way to ...
A potential new treatment for motor neurone disease (MND) developed by a company spun-out of The University of Queenslan...
Seoul National University Bundang Hospital (SNUBH), CurePSP, Inc. and GemVax & KAEL Co., have announced the est...
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, has announced i...
A topical cream to help prevent and treat skin cancers in organ transplant patients is a step closer to development. The...
The Albanese government is supporting the next phase of the search for a cure for Type 1 Diabetes through a $50.1 millio...
The Cardiovascular Disease National Collaborative Enterprise (CADENCE) and Medera Inc. (“Merdera”)’s S...
Numab Therapeutics AG, a clinical stage biotechnology company advancing a proprietary pipeline of multi-specific antibod...
Lilly Digital Health and Lilly Centre for Clinical Pharmacology (LCCP), a wholly owned subsidiary of U.S.-based Eli Lill...
A team of researchers, led by Assistant Professor Minh Le from the Institute for Digital Medicine (WisDM) and Department...
Scientists from Singapore's Duke-NUS Medical School and their collaborators have identified an inherited genetic variati...
Could you explain more about the advantages of using iPSCs from cord blood for creating your ‘off-the-shelf’...
Diabetes affects 1 in 11 adults, or about 90 million people, in South-East Asia, with this number projected to rise to 1...
MilliporeSigma, the US and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has announced a $76 million e...
The clinical-stage biopharmaceutical company, Seaport Therapeutics, which uses a unique drug delivery platform orig...
HELP Therapeutics Co. Ltd, a clinical-stage cell therapy company, announced that the U.S. Food and Drug Administrat...
Isolere Bio by Donaldson, an innovative bioprocessing technology provider, proudly announces the availability of researc...
Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) are working on a t...
In a candid conversation with Ankit Kankar from BioSpectrum Asia, Dr. Boro Dropulić, Executive Director of Caring Cross...
The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, US will receive $3.2 mill...
National University of Singapore (NUS) and Imperial College London have announced a new partnership to strengthen resear...
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufactur...
The government is investing almost $18 million in a world-first Australian research project that will trial a drug disco...
The global population is aging rapidly, and sarcopenia, a condition that severely diminishes quality of life in older ad...
Bio-Sourcing, a pioneering Belgian biotherapeutic company, announces the award of €2.5M in grants and €10M in ...
Antibody Engineering & Therapeutics Asia: Date: October 21 – 23, 2024Location: The Westin Miyako Kyoto Antib...
In a world first, a new wearable device developed by Australia's Monash University researchers will help to record the i...
GSK Singapore has announced that the Singapore Health Sciences Authority (HSA) has approved a new indication for Jemperl...
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Or...
Department of Health – Abu Dhabi (DoH) has provided revolutionary gene transfer therapy for Duchenne muscular dyst...
Under an important initiative aimed at transforming healthcare in the Kingdom of Saudi Arabia, Boston Oncology and King ...
EVRYSDI® (risdiplam) has been added to the Singapore Ministry of Health’s (MOH) list of medicines covered...
The global CNS disorders market, in 2022, was valued at $116 billion, ranking it as the fourth largest therapy area behi...
Dr Samantha SHAN, Research Assistant Professor of the School of Optometry of The Hong Kong Polytechnic University (PolyU...
Triastek Inc., a global leader in 3D printing pharmaceuticals, has entered into a research collaboration and platform te...
Scientists at the University of Sydney, Australia and Liverpool School of Tropical Medicine, UK have made a remarkable d...
GC Cell Corporation and Taiwan-based Lukas Biomedical has formally signed an international strategic cooperation agreeme...
A team of scientists led by Associate Professor Ashley St John from Duke-NUS’ Emerging Infectious D...
Acute graft-versus-host disease (aGVHD) is a medical condition that occurs when donor immune cells attack the recipient'...
The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) has conducted a large cohort study among ...
TMS Co. has entered into an exclusive worldwide license agreement with Hokkaido University concerning a therapeuti...
Union Minister for Science and Technology, Government of India, Dr Jitendra Singh has unveiled the results of the 15th r...
A University of Sydney team have successfully created a transparent microchip with the potential to reduce the testing o...
A study led by clinician-scientists and scientists from the National Cancer Centre Singapore (NCCS) and A*STAR’s G...
Nasopharyngeal carcinoma (NPC) is a cancer type strongly associated with Epstein-Barr virus (EBV) infection. The Chinese...
A new biotech company launched on 18th June in Australia will use a world-leading technology to target cancers that are ...
To increase patient access to affordable, advanced genomic testing for cancer in Singapore, Thermo Fisher Scientific Inc...
Having previously pivoted towards medical devices more than 10 years ago, Singapore has recently seen a biotech resurgen...
Researchers at University of Auckland in New Zealand are working on an innovative way to treat an aggressive blood cance...
While in Geneva to advance Australia’s interests at the World Health Organization’s (WHO) World Health Assem...
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, has signed a Me...
Traditional chemotherapy often poses significant challenges, including severe side effects, damage to healthy tissue and...
Scientists from Nanyang Technological University, Singapore (NTU Singapore) and Chiba University in Japan have shown how...
Precision medicine is becoming more prevalent, with pharmaceutical companies and healthcare regimen to develop highly ta...
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, ...
A randomised, placebo-controlled clinical trial led by a collaboration between Duke-NUS Medical School, National Heart C...
OBiO Technology, a world leading contract development and manufacturing organisation (CDMO) for cell and gene thera...
Longstanding alliance between Evotec and CHDI to enable the development of therapeutics for Huntington’s disease...
A research team at Osaka University, Japan will start an investigator-initiated clinical trial for refractory prostate c...
Researchers from Duke-NUS Medical School in Singapore have found that a new class of light-sensitive proteins are capabl...
A team of researchers led by Associate Professor Alfredo Franco-Obregón from the NUS Institute for Health Innovat...
The urgency to address the myopia epidemic among children has never been more pressing. Recent studies reveal an al...
To mark World Clinical Trials Day on May 20, Victorian Deputy Premier and Minister for Medical Research, Ben Carro...
As Asia establishes itself as the global hub for clinical trials, Singapore is bolstering its position as the preferred ...
The Asia Pacific, Middle East and Africa (APMA) region represents almost half of the world's population but healthcare a...
Johnson & Johnson’s first-in-class, bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell-redirectin...
Singapore's National University Hospital (NUH) and leading RNA technology company, Mirxes have officialy unveiled the NU...
Glioblastoma is an often fatal form of brain cancer, with only five per cent of patients surviving beyond five years. Th...
A range of hyper accurate cancer drugs is in production at a newly opened research and manufacturing hub at The Universi...
Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization (CRDM...
The SARS CoV-2 infection can cause a wide range of recurring or persistent health concerns among the populations infecte...
A team of scientists from A*STAR’s Genome Institute of Singapore (GIS) and Bioinformatics Institute (BII) has deve...
Guangzhou-Israel Biotechnology Fund (GIBF) has invested $10 million in Nectin Therapeutics. Israel-b...
Rabies is a neglected zoonotic disease caused by RNA virus from Rhabdoviridae family, potentially fatal if not treated. ...
In a groundbreaking study published in Cell Research, researchers from the Yong Loo Lin School of Medicine at the Nation...
Research led by the University of Sydney and Sydney Local Health District has developed a new type of oral insulin bas...
Ora, Inc., a US-based ophthalmology contract research organisation (CRO), has announced a strategic, exclusive partnersh...
How is Agilent advancing cell and gene therapy modalities to enable next-gen therapeutics and applications? What are A...
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore fa...
The Paula Fox Melanoma and Cancer Centre, a partnership between Monash University, The Alfred and Minderoo Foundation, i...
In Hong Kong, one in three adults over the age of 65 have diabetes. To improve the management of this group of older adu...
South Korea-based biotech startup OSR Holdings has signed a Memorandum of Understanding (MoU) with SillaJen, a Kosdaq-li...
SCG Cell Therapy (SCG) and the Agency for Science, Technology and Research (A*STAR) have announced the launch joint labo...
The National University Hospital (NUH) in Singapore is embarking on a major initiative to establish the N...
Seaport Therapeutics, a clinical-stage biopharmaceutical company based around a unique drug delivery platform originally...
Serum Institute of India (SII), the world’s largest vaccine manufacturer, has joined forces with Univercells,...
Scientists have discovered a target for the development of a drug to combat a bacterium that can cause chronic lung infe...
Monash Partners Comprehensive Cancer Consortium (MPCCC) has announced the recipients of the Precision Treatment Accelera...
Ascend Advanced Therapies (Ascend), a total solutions gene therapy development partner, has acquired the CMC ...
Scientists at Nanyang Technological University (NTU), Singapore have successfully grown ‘mini kidneys’ in th...
Researchers at the University of Otago in New Zealand are recruiting for a novel trial, combining use of the drug ketami...
In a significant breakthrough, researchers from the Swiss Tropical and Public Health Institute (Swiss TPH) and...
Lion TCR has forged a strategic partnership with the National University of Singapore Guangzhou Research Translation and...
Researchers from the Institute for Functional Intelligent Materials (I-FIM) at the National University of Singapore (NUS...
US-based Charles River Laboratories International, Inc. and National University of Singapore’s (NUS) Yon...
